Kinetics of finite dose absorption through skin 2: Volatile compounds

Journal of Pharmaceutical Sciences

Volumn 95, Issue 2, 2006, Pages 268-280

  Kasting, Gerald B ^a   Miller, Matthew A ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Evaporation; Mathematical model; Percutaneous absorption; Risk assessment; Skin

Indexed keywords

BENZYL ALCOHOL; VOLATILE AGENT;

ARTICLE; CONTROLLED STUDY; DIFFUSION; DOSIMETRY; DRUG ABSORPTION; DRUG DISPOSITION; EVAPORATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MEMBRANE PERMEABILITY; SKIN ABSORPTION; STEADY STATE; STRATUM CORNEUM;

EID: 32644434562     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20497     Document Type: Article

References (44)

1. Scheuplein RJ, Ross LW. 1974. Mechanism of percutaneous absorption V. Percutaneous absorption of solvent deposited solids. J Invest Dermatol 62:353-360.
2. Albery WJ, Hadgraft J. 1979. Percutaneous absorption: Theoretical description. J Pharm Pharmacol 31:129-139.
3. Guy RH, Hadgraft J. 1980. A theoretical description relating skin penetration to the thickness of the applied medicament. Int J Pharm 6:321-332.
4. Kubota K, Ishizaki T. 1986. A diffusion-diffusion model for percutaneous drug absorption. J Pharm Biopharm 14:409-440.
5. Bhatt PP, Hanna MS, Szeptycki P, Higuchi T. 1989. Finite dose transport of drugs in liquid formulations through stratum corneum. Analytical solution to a diffusion model. Int J Pharm (Kidlington) 50:197-204.
6. Anissimov YG, Roberts MS. 2001. Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids. J Pharm Sci 90:504-520.
7. Kasting GB. 2001. Kinetics of finite dose absorption 1. Vanillylnonanamide. J Pharm Sci 90:202-212.
8. Santhanam A, Miller MA, Kasting GB. 2005. Absorption and evaporation of N,N-diethyl-m-toluamide (DEET) from human skin in vitro. Toxicol Appl Pharmacol 204:81-90.
9. Miller MA, Bhatt V, Kasting GB. Absorption and evaporation of benzyl alcohol from skin. J Pharm Sci 95:281-291.
10. Cleek RL, Bunge AL. 1993. A new method for estimating dermal absorption from chemical exposure. 1. General approach. Pharm Res 10: 497-506.
11. Cussler EL. 1997. Diffusion: Mass transfer in fluid systems. Cambridge: Cambridge University Press. pp 50-55.
12. Monteiro-Riviere NA, Inman AO, Riviere JE. 1994. Identification of the pathway of iontophoretic drug delivery: Light and ultrastructural studies using mercuric chloride in pigs. Pharm Res 11: 251-256.
13. Williams PL, Carver MP, Riviere JE. 1990. A physiologically relevant pharmacokinetic model of xenobiotic percutaneous absorption utilizing the isolated perfused porcine skin flap. J Pharm Sci 79:305-311.
14. Akhter SA, Barry BW. 1985. Absorption through human skin of ibuprofen and flurbiprofen; effect of dose variation, deposited drug films, occlusion and the penetration enhancer N-methyl-2-pyrrolidone. J Pharm Pharmacol 37:27-37.
15. Stinchcomb AL, Pirot F, Touraille GD, Bunge AL, Guy RH. 1999. Chemical uptake into human stratum corneum in vivo from volatile and non-volatile solvents. Pharm Res 16:1288-1293.
16. Parry GE, Dunn P, Shah VP, Pershing LK. 1992. Acyclovir bioavailability in human skin. J Invest Dermatol 98:856-863.
17. Crank J. 1975. The mathematics of diffusion. Oxford: Clarendon Press. pp 11-13.
18. Wang T-F. 2003. Microscopic models for the structure and permeability of the stratum corneum barrier layer of skin. PhD thesis. Department of Chemical Engineering State University of New York, Buffalo.
19. Wang T-F, Kasting GB, Nitsche JM. A multiphase microscopic model for stratum corneum permeability. I. Formulation, solution and illustrative results for representative compounds. J Pharm Sci, in press.
20. Frasch HF, Barbara AM. 2003. Steady-state flux and lag time in the stratum corneum lipid pathway: Results from finite element models. J Pharm Sci 92:2196-2207.
21. Kretsos K, Kasting GB, Nitsche JM. 2004. Distributed diffusion-clearance model for transient drug distribution within the skin. J Pharm Sci 93:2820-2835.
22. Lyman WJ, Reehl WF, Rosenblatt DH. 1982. Handbook of chemical property estimation. New York: McGraw-Hill. Chapters 15 and 16.
23. Peress J. 2003. Estimate evaporative losses from spills. Chem Eng Prog:32-34.
24. N'Dri-Stempfer B, Bunge AL. 2005. How much can evaporation of dermally absorbed chemical reduce the systemically absorbed dose? In 2nd International Conference on Occupational and Environmental Exposure of Skin to Chemicals. S. Soderholm, editor, Stockholm, Sweden. pp 145-146. URL: http://www.cdc.gov/niosh/ topics/skin/OEESC2/AbPost081Bunge.html
25. Cooper ER, Berner B. 1985. Finite dose pharmacokinetics of skin penetration. J Pharm Sci 74:1100-1102.
26. Carslaw HS, Jaeger JC. 1959. Conduction of heat in solids. Oxford: Clarendon Press. p 120.
27. Frasch HF. 2002. A random walk model of skin permeation. Risk Anal 22:265-276.
28. Frasch HF, Barbaro AM. 2005. The transient dermal dose problem. In 2nd International Conference on Occupational and Environmental Exposures of Skin to Chemicals. S. Soderholm, editor, Stockholm, Sweden. pp 70-73. URL: http://www.cdc.gov/niosh/topics/skin/OEESC2/AbPost017Frasch.html
29. Monteith JL, Unsworth MH. 1990. Principles of environmental physics. Oxford: Butterworth-Heinemann. pp 112-114.
30. Potts RO, Guy RH. 1992. Predicting skin permeability. Pharm Res 9:663-669.
31. Johnson ME, Blankschtein D, Langer R. 1997. Evaluation of solute permeation through the stratum corneum: Lateral bilayer diffusion as the primary transport mechanism. J Pharm Sci 86:1162-1172.
32. Kasting GB, Saiyasombati P. 2001. A physicochemical properties based model for estimating evaporation and absorption rates of perfumes from skin. Int J Cosmet Sci 23:49-58.
33. Santhanam A, Miller MA, Kasting GB. 2005. Absorption and evaporation of N,N-diethyl-m-toluamide (DEET) from human skin in vitro. Toxicol Appl Pharmacol 204:81-90.
34. Dahlquist G, Bjork A. 1974. Numerical methods. Englewood Cliffs, NJ: Prentice Hall. p 388.
35. Guy RA, Hadgraft J, Maibach HI. 1982. A pharmacokinetic model for percutaneous absorption. Int J Pharm 11:119-129.
36. Guy RA, Hadgraft J. 1983. Physicochemical interpretation of the pharmacokinetics of percutaneous absorption. J Pharm Biopharm 11:189-203.
37. McCarley KD, Bunge AL. 2001. Pharmacokinetic models of dermal absorption. J Pharm Sci 90:1699-1719.
38. Anissimov YG, Roberts MS. 2004. Diffusion modeling of percutaneous absorption kinetics: 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics. J Pharm Sci 93:470-487.
39. Saiyasombati P, Kasting GB. 2003. Disposition of benzyl alcohol following topical application to human skin in vitro. J Pharm Sci 92:2128-2139.
40. Saiyasombati P, Kasting GB. 2003. Two-stage kinetic analysis of fragrance evaporation and absorption from skin. Int J Cosmet Sci 25:235-243.
41. Saiyasombati P, Kasting GB. 2004. Prediction of fragrance headspace concentrations from physicochemical properties. Perfum Flavor 29:38-47.
42. Saiyasombati P, Kasting GB. 2004. Evaporation of benzyl alcohol from human skin in vivo. J Pharm Sci 93:515-520.
43. Kasting GB. 2005. Estimating the absorption of volatile compounds applied to skin. In: Riviere JE, editor. Dermal absorption models in toxicology and pharmacology. New York: Taylor and Francis. pp 175-188.
44. Nitsche JM, Wang T-F, Kasting GB. A two-phase analysis of solute partitioning into the straturm corneuim. J Pharm Sci, in press.